Quarterly report pursuant to Section 13 or 15(d)

Warrants and Derivative Liabilities (Detail Textuals)

v3.19.3
Warrants and Derivative Liabilities (Detail Textuals) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Feb. 16, 2018
Jan. 19, 2018
Mar. 31, 2019
Sep. 30, 2019
Sep. 30, 2018
Class of Warrant or Right [Line Items]          
Warrants issued in connection with convertible multi draw credit agreement related party value     $ 716,110    
Warrant vested aggregate fair value utilizing the Black-Scholes option pricing model       $ (2,024,660) $ 1,653,477
Issuance costs related to warrant liability         $ 137,192
Warrant | Emerald Health Sciences Inc          
Class of Warrant or Right [Line Items]          
Number of warrants issued 3,400,000 40,800,000   5,000,000  
Total number of warrants issued 44,200,000 44,200,000      
Warrant exercise price $ 0.10 $ 0.10      
Term of warrant 5 years 5 years      
Warrants issued in connection with convertible multi draw credit agreement related party value       $ 716,110  
Warrant vested aggregate fair value utilizing the Black-Scholes option pricing model       $ 1,830,573  
Emerald Warrant Liabilities          
Class of Warrant or Right [Line Items]          
Value of common stock called by warrants $ 5,700,000 $ 4,700,000